Evid Invest
Who owns KRSAWhat KRSA owns — n/a

Who owns Korsana Biosciences, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of KRSA from SEC Form 13F filings across 44 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 44 institutions disclosed 39.5M shares of Korsana Biosciences, Inc. worth $1.27B — about 292% of shares outstanding; the largest disclosed holder is Fairmount Funds Management LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

44

13F holders

$1.27B

value, 2026 filers

292%

of shares outstanding (39.5M sh)

44

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of KRSA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Fairmount Funds Management LLCNEW9.1M$291.3M18.3%67.3%new
2TCG Crossover Management, LLCNEW4.5M$145.6M4.1%33.6%new
3Venrock Adviser, LLCNEW4.5M$145.6M7.1%33.6%new
4FMR LLCNEW3.2M$102.4M0.0%23.7%new
5JPMORGAN CHASE & CONEW2.7M$91.4M0.0%19.9%new
6FCPM III SERVICES B.V.NEW2.2M$70.1M6.6%16.2%new
7SanofiNEW2.0M$63.8M10.1%14.7%new
8Foresite Capital Management VI LLCNEW1.4M$45.8M8.1%10.6%new
9GENERAL ATLANTIC, L.P.NEW1.4M$43.7M1.8%10.1%new
10RA CAPITAL MANAGEMENT, L.P.NEW892,743$28.6M0.3%6.6%new
11Commodore Capital LPNEW877,022$28.1M2.2%6.5%new
12Vivo Capital, LLCNEW877,020$28.1M3.1%6.5%new
13RTW INVESTMENTS, LPNEW877,020$28.1M0.3%6.5%new
14Janus Henderson Group Ltd.NEW789,319$25.3M0.0%5.8%new
15SR ONE CAPITAL MANAGEMENT, LPNEW613,915$19.6M1.7%4.5%new
16Paradigm Biocapital Advisors LPNEW613,914$19.6M0.4%4.5%new
17Remedium Capital Partners, LLCNEW518,500$16.6M6.1%3.8%new
18Kalehua Capital Management LLCNEW442,653$14.2M10.7%3.3%new
19Spruce Street Capital LPNEW338,951$10.3M1.6%2.5%new
20Duquesne Family Office LLCNEW278,561$8.9M0.2%2.1%new
21Affinity Asset Advisors, LLCNEW263,106$8.4M0.3%1.9%new
22Vestal Point Capital, LPNEW263,105$8.4M0.2%1.9%new
23Woodline Partners LPNEW219,255$7.0M0.0%1.6%new
24NEXTBio Capital Management LPNEW175,403$5.6M2.4%1.3%new
25MARSHALL WACE, LLPNEW131,552$4.2M0.0%1%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.